Kaken Pharmaceutical Co., Ltd. (KKPCF)

Kaken Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Market Capitalization	1,068	866	1,042	1,211	1,502	1,819
Market Cap Growth	20.62%	-16.86%	-14.02%	-19.34%	-17.44%	0.90%
Enterprise Value	542	454	544	697	916	1,261
Last Close Price	28.09	23.95	29.27	39.84	36.80	-
PE Ratio	8.18	16.32	25.45	15.41	12.39	10.11
PS Ratio	1.80	1.82	1.90	1.94	2.22	2.19
PB Ratio	1.08	0.91	1.01	1.06	1.22	1.52
P/TBV Ratio	1.14	0.96	1.07	1.14	1.23	1.53
P/FCF Ratio	-	182.95	19.06	14.21	13.39	7.74
P/OCF Ratio	-	50.83	14.96	11.03	11.55	7.13
EV/Sales Ratio	0.84	0.95	0.99	1.11	1.35	1.52
EV/EBITDA Ratio	-	5.60	6.85	4.33	5.04	4.63
EV/EBIT Ratio	3.00	7.22	9.04	4.96	5.69	5.12
EV/FCF Ratio	-	95.94	9.96	8.17	8.16	5.36
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.03	0.03
Debt / EBITDA Ratio	-	0.31	0.36	0.20	0.19	0.13
Debt / FCF Ratio	-	5.38	0.53	0.37	0.31	0.15
Asset Turnover	0.52	0.43	0.44	0.46	0.47	0.57
Inventory Turnover	1.95	2.05	2.19	2.28	2.48	2.98
Quick Ratio	3.75	4.68	4.49	4.98	4.60	4.39
Current Ratio	4.38	5.62	5.27	5.81	5.34	5.00
Return on Equity (ROE)	13.90%	5.72%	3.95%	6.96%	10.13%	15.52%
Return on Assets (ROA)	9.01%	3.52%	3.02%	6.49%	6.92%	10.56%
Return on Capital (ROIC)	10.75%	4.13%	3.54%	7.56%	8.16%	12.88%
Return on Capital Employed (ROCE)	15.90%	6.20%	5.50%	11.70%	12.50%	19.50%
Earnings Yield	12.22%	6.13%	3.93%	6.49%	8.07%	9.89%
FCF Yield	-	0.55%	5.25%	7.03%	7.47%	12.93%
Dividend Yield	4.87%	4.14%	3.85%	3.10%	3.69%	-
Payout Ratio	-	70.49%	103.84%	59.84%	43.35%	30.44%
Buyback Yield / Dilution	-0.62%	-0.44%	1.07%	1.59%	1.41%	1.84%
Total Shareholder Return	4.25%	3.70%	4.93%	4.69%	5.09%	1.84%

Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.